These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
481 related articles for article (PubMed ID: 12152164)
1. Immunohistochemical staining for thyroid transcription factor-1: a helpful aid in discerning primary site of tumor origin in patients with brain metastases. Srodon M; Westra WH Hum Pathol; 2002 Jun; 33(6):642-5. PubMed ID: 12152164 [TBL] [Abstract][Full Text] [Related]
2. Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens. Chhieng DC; Cangiarella JF; Zakowski MF; Goswami S; Cohen JM; Yee HT Cancer; 2001 Oct; 93(5):330-6. PubMed ID: 11668468 [TBL] [Abstract][Full Text] [Related]
3. Thyroid transcription factor-1 staining is useful in identifying brain metastases of pulmonary origin. Prok AL; Prayson RA Ann Diagn Pathol; 2006 Apr; 10(2):67-71. PubMed ID: 16546039 [TBL] [Abstract][Full Text] [Related]
4. Utility of thyroid transcription factor-1 and cytokeratin 20 in identifying the origin of metastatic carcinomas of cervical lymph nodes. Roh MS; Hong SH J Korean Med Sci; 2002 Aug; 17(4):512-7. PubMed ID: 12172048 [TBL] [Abstract][Full Text] [Related]
5. [Diagnostic value of the monoclonal antibody to thyroid transcription factor -1(TTF-1) in CNS metastases. An immunohistochemical study of 65 cases]. Romeike BF; Feiden W Pathologe; 2002 Jul; 23(4):292-6. PubMed ID: 12185782 [TBL] [Abstract][Full Text] [Related]
6. Thyroid transcription factor-1 is the superior immunohistochemical marker for pulmonary adenocarcinomas and large cell carcinomas compared to surfactant proteins A and B. Kaufmann O; Dietel M Histopathology; 2000 Jan; 36(1):8-16. PubMed ID: 10632746 [TBL] [Abstract][Full Text] [Related]
7. Ribonucleic Acid In Situ Hybridization Is a More Sensitive Method Than Immunohistochemistry in Detection of Thyroid Transcription Factor 1 and Napsin A Expression in Lung Adenocarcinomas. Shi J; Liu H; Ma XJ; Chen Z; He MX; Luo Y; Lin F Arch Pathol Lab Med; 2016 Apr; 140(4):332-40. PubMed ID: 27028392 [TBL] [Abstract][Full Text] [Related]
8. Expression of thyroid transcription factor-1 in pulmonary and extrapulmonary small cell carcinomas and other neuroendocrine carcinomas of various primary sites. Kaufmann O; Dietel M Histopathology; 2000 May; 36(5):415-20. PubMed ID: 10792482 [TBL] [Abstract][Full Text] [Related]
9. The value of thyroid transcription factor-1 in cytologic preparations as a marker for metastatic adenocarcinoma of lung origin. Hecht JL; Pinkus JL; Weinstein LJ; Pinkus GS Am J Clin Pathol; 2001 Oct; 116(4):483-8. PubMed ID: 11601132 [TBL] [Abstract][Full Text] [Related]
10. The Value of Cytokeratin 5/6, p63 and Thyroid Transcription Factor-1 in Adenocarcinoma, Squamous Cell Carcinoma and Non-Small-Cell Lung Cancer of the Lung. Argon A; Nart D; Veral A Turk Patoloji Derg; 2015; 31(2):81-8. PubMed ID: 25944390 [TBL] [Abstract][Full Text] [Related]
11. The utility and limitation of thyroid transcription factor-1 protein in primary and metastatic pulmonary neoplasms. Chang YL; Lee YC; Liao WY; Wu CT Lung Cancer; 2004 May; 44(2):149-57. PubMed ID: 15084379 [TBL] [Abstract][Full Text] [Related]
13. Utility of a novel triple marker (combination of thyroid transcription factor 1, Napsin A, and P40) in the subclassification of non-small cell lung carcinomas using fine-needle aspiration cases. Sharma R; Wang Y; Chen L; Gurda GT; Geddes S; Gabrielson E; Askin F; Li QK Hum Pathol; 2016 Aug; 54():8-16. PubMed ID: 27045515 [TBL] [Abstract][Full Text] [Related]
14. Surfactant proteins and thyroid transcription factor-1 in pulmonary and breast carcinomas. Bejarano PA; Baughman RP; Biddinger PW; Miller MA; Fenoglio-Preiser C; al-Kafaji B; Di Lauro R; Whitsett JA Mod Pathol; 1996 Apr; 9(4):445-52. PubMed ID: 8729987 [TBL] [Abstract][Full Text] [Related]
15. Value of thyroid transcription factor-1 immunostaining in distinguishing small cell lung carcinomas from other small cell carcinomas. Ordóñez NG Am J Surg Pathol; 2000 Sep; 24(9):1217-23. PubMed ID: 10976695 [TBL] [Abstract][Full Text] [Related]
16. Diagnostic utility of thyroid transcription factor-1 expression in adenocarcinomas presenting in serous fluids. Afify AM; al-Khafaji BM Acta Cytol; 2002; 46(4):675-8. PubMed ID: 12146029 [TBL] [Abstract][Full Text] [Related]
17. Thyroid transcription factor-1 and cytokeratins 7 and 20 in pulmonary and breast carcinoma. Harlamert HA; Mira J; Bejarano PA; Baughman RP; Miller MA; Whitsett JA; Yassin R Acta Cytol; 1998; 42(6):1382-8. PubMed ID: 9850647 [TBL] [Abstract][Full Text] [Related]
18. Expression of thyroid transcription factor-1 in brain metastases: a useful indicator of pulmonary origin. Chuang WY; Yeh CJ; Chu PH; Liao CC; Wu CT; Chuang CC; Pai PC; Tseng CK; Jung SM; Wei KC; Chang CN J Clin Neurosci; 2008 Jun; 15(6):643-6. PubMed ID: 18413286 [TBL] [Abstract][Full Text] [Related]
19. Cytomorphologic overlap of differentiated thyroid carcinoma and lung adenocarcinoma and diagnostic value of TTF-1 and TGB on cytologic material. Sathiyamoorthy S; Maleki Z Diagn Cytopathol; 2014 Jan; 42(1):5-10. PubMed ID: 23637102 [TBL] [Abstract][Full Text] [Related]